慢性咳嗽の世界市場レポート 2025年

慢性咳嗽市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.7％で、128億9,000万米ドルに成長します。予測期間の成長は、特定の経路をターゲットとする新たな治療法、逆流に関連する咳嗽に対する理解の深まり、禁煙に対する世界の取り組み、環境・労働衛生政策などに起因すると考えられます。予測期間における主な動向としては、診断技術の進歩、患者中心のアプローチ、神経因性咳嗽の治療革新、遠隔医療による管理、中枢性感作に関する調査などが挙げられます。

咳の有病率の急増は、近い将来慢性咳嗽市場の拡大を促進すると予測されます。咳は気道から刺激物や異物を排出する自然な反射であり、8週間以上続く場合は慢性と呼ばれます。咳全体の症例数の増加は、慢性咳嗽の症例数の増加と直接相関しています。例えば、フロリダ州保健局の2022年3月のデータによると、米国では2021年に合計80件の症例が報告され、咳と百日咳の発生率はそれぞれ10万人当たり41.0件と1.4件でした。同様に、デンマークのStatens Serum Institutの調査結果では、2022年11月から2023年4月までの百日咳症例が前年比41％増加しました。百日咳をはじめとする咳関連疾患の有病率の上昇は、慢性咳嗽市場の成長の原動力となっています。

喫煙やタバコの使用率が上昇していることが、今後の慢性咳嗽市場の成長を牽引すると予測されます。喫煙は、物質（通常はタバコ）を燃やし、その結果生じる煙を血液中に吸い込んだり吸収したりすることです。この行為は、気道を刺激し、慢性気管支炎の一因となり、粘液産生を増加させ、肺機能を低下させ、免疫系を弱め、咳反射を妨げ、肺がんのリスクを高める。例えば、2024年9月、米国を拠点とする国立公衆衛生機関である疾病対策予防センター（CDC）は、2022年には米国の成人4,920万人（19.8％）、ほぼ5人に1人がタバコ製品を現在使用していると報告しています。したがって、喫煙とタバコの消費量の増加が慢性咳嗽市場の拡大を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界慢性咳嗽 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の慢性咳嗽市場：成長率分析
• 世界の慢性咳嗽市場の実績：規模と成長, 2019-2024
• 世界の慢性咳嗽市場の予測：規模と成長, 2024-2029, 2034F
• 世界慢性咳嗽総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の慢性咳嗽市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• コルチコステロイド
• 充血除去薬
• 併用薬
• 抗生物質
• 酸阻害剤
• その他の薬物クラス
• 世界の慢性咳嗽市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 吸入
• 注射可能
• その他の投与経路
• 世界の慢性咳嗽市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門センター
• その他のエンドユーザー
• 世界の慢性咳嗽市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の慢性咳嗽市場抗ヒスタミン薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 第一世代抗ヒスタミン薬
• 第二世代抗ヒスタミン薬
• 世界の慢性咳嗽市場、コルチコステロイドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吸入コルチコステロイド
• 全身性コルチコステロイド
• 世界の慢性咳嗽市場充血除去薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口充血除去薬
• 鼻づまり解消薬
• 世界の慢性咳嗽市場、複合薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬と充血除去薬の組み合わせ
• 咳止め薬と去痰薬の組み合わせ
• 世界の慢性咳嗽市場抗生物質の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• マクロライド
• ペニシリン
• セファロスポリン
• 世界の慢性咳嗽市場、酸遮断薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロトンポンプ阻害剤（PPI）
• H2受容体拮抗薬
• 世界の慢性咳嗽市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粘液溶解薬
• 咳止め薬
• ハーブ療法

第7章 地域別・国別分析

• 世界の慢性咳嗽市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の慢性咳嗽市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性咳嗽市場：競合情勢
• 慢性咳嗽市場：企業プロファイル
  • Tris Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Glaxo SmithKline Plc
• Merck KGaA
• Reckitt Benckiser Group plc
• Glenmark Pharmaceuticals Ltd
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Aurobindo Pharma Ltd.
• Cipla Limited
• Apotex Inc.
• Hikma Pharmaceuticals Plc
• Amneal Pharmaceuticals LLC
• Mount Sinai Health System

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 慢性咳嗽市場2029：新たな機会を提供する国
• 慢性咳嗽市場2029：新たな機会を提供するセグメント
• 慢性咳嗽市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chronic cough is characterized by persistent coughing lasting eight weeks or more, often indicative of an underlying condition such as asthma, allergies, or respiratory infections.

The primary drug classes for chronic cough include antihistamines, corticosteroids, decongestants, combination drugs, antibiotics, acid blockers, and others. Antihistamines are medications designed to address allergies by counteracting the physiological effects of histamines. These drugs can be administered through various routes, including oral, inhalational, injectable, and others, catering to settings such as hospitals, homecare, specialty centers, and more. Distribution channels for chronic cough medications encompass hospital pharmacies, online pharmacies, and retail pharmacies.

The chronic cough market research report is one of a series of new reports from The Business Research Company that provides chronic cough market statistics, including chronic cough industry global market size, regional shares, competitors with a chronic cough market share, detailed chronic cough market segments, market trends and opportunities, and any further data you may need to thrive in the chronic cough industry. This chronic cough market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic cough market size has grown strongly in recent years. It will grow from $8.22 billion in 2024 to $8.9 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to prevalence of underlying respiratory conditions, environmental factors and air pollution, smoking and tobacco use, respiratory infections, allergies and environmental sensitivities

The chronic cough market size is expected to see strong growth in the next few years. It will grow to $12.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging therapies targeting specific pathways, increasing understanding of reflux-related cough, global efforts in smoking cessation, environmental and occupational health policies. Major trends in the forecast period include advancements in diagnostic technologies, patient-centric approaches, therapeutic innovations in neurogenic cough, telehealth for chronic cough management, research on central sensitization.

The surge in the prevalence of cough incidents is anticipated to drive the expansion of the chronic cough market in the foreseeable future. Coughing is a natural reflex that expels irritants or foreign substances from the airways, and when it persists for a duration exceeding eight weeks, it is termed as chronic. The increase in overall cough instances directly correlates with the rise in chronic cough cases. For example, as per March 2022 data from Florida Health, the US reported a total of 80 cases in 2021, marking an incidence of 41.0 and 1.4 per 100,000 individuals for cough and pertussis cases, respectively. Similarly, findings from the Statens Serum Institut in Denmark revealed a 41% increase in pertussis cases from November 2022 to April 2023 compared to the previous year. This escalating prevalence of cough-related conditions, notably pertussis, is a driving force behind the chronic cough market's growth.

The rising prevalence of smoking and tobacco use is projected to drive the growth of the chronic cough market in the future. Smoking involves burning a substance, usually tobacco, and inhaling or absorbing the resulting smoke into the bloodstream. This practice irritates the airways, contributes to chronic bronchitis, increases mucus production, diminishes lung function, weakens the immune system, interferes with the cough reflex, and raises the risk of lung cancer. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based national public health agency, reported that in 2022, 49.2 million adults (19.8%) in the U.S.-nearly 1 in 5-indicated current use of tobacco products. Therefore, the growing prevalence of smoking and tobacco consumption is driving the expansion of the chronic cough market.

Major companies in the chronic cough market are focusing on developing innovative products like biosimilars to enhance their market position. Biosimilars are used to treat conditions such as cancer, autoimmune diseases, and diabetes, providing cost-effective alternatives to existing biologics. For example, in July 2024, Sandoz, a Switzerland-based pharmaceutical company, launched its biosimilar Pyzchiva (ustekinumab) across Europe, aimed at treating chronic inflammatory diseases like plaque psoriasis, psoriatic arthritis, and Crohn's disease. This biosimilar is particularly noteworthy as it is the first of its kind available in Europe with all strengths of the reference medicine, including the initiation dose for Crohn's disease. Developed in collaboration with Samsung Bioepis, Sandoz intends to improve access to effective treatments for millions affected by these conditions. The launch underscores Sandoz's commitment to offering affordable healthcare solutions and enhancing the quality of life for patients throughout Europe.

Leading enterprises in the chronic cough sector are emphasizing technologically advanced products such as cough detectors to drive market growth. Cough detection entails the identification and categorization of cough sounds using cutting-edge technologies such as artificial intelligence (AI) and machine learning. For instance, in May 2023, Hyfe Inc., a US-based company specializing in acoustic epidemiology with a focus on analyzing health sounds, particularly coughs, introduced a digital therapeutic. This innovative digital therapeutic aims to improve patients' lives by providing comprehensive care for chronic cough sufferers. Leveraging Hyfe's expertise in cough monitoring and its extensive database of over 700 million sounds, this digital therapy offers an end-to-end solution for managing coughs. By integrating speech therapy for cough treatment and suppression alongside breathing exercises accessible via mobile devices, this digital therapeutic addresses the needs of chronic cough patients.

In September 2022, the US-based biopharmaceutical company Pfizer Inc. successfully acquired the ASX-listed digital health startup ResApp Health for $115 million. This strategic acquisition was undertaken by Pfizer to strengthen its product portfolio and extend its footprint in key healthcare technology domains. ResApp is a smartphone application known for analyzing coughing patterns, accurately identifying respiratory conditions such as asthma, pneumonia, bronchiolitis, croup, and chronic obstructive pulmonary disease (COPD). ResApp Health, headquartered in Australia, is a healthcare solutions company that specializes in the management of chronic cough. This acquisition reflects Pfizer's commitment to leveraging innovative digital health solutions for enhanced healthcare offerings.

Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic cough market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic cough market consists of revenues earned by entities by providing services such as chest X-ray or CT scan services, lung function tests, and sputum culture. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic cough market also includes sales of cough suppressants, expectorants, inhalers, and allergy medications which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Cough Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic cough market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic cough ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic cough market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes
• 2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route Of Administrations
• 3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• Subsegments:
• 1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines
• 2) By Corticosteroids: Inhaled Corticosteroids; Systemic Corticosteroids
• 3) By Decongestants: Oral Decongestants; Nasal Decongestants
• 4) By Combination Drug: Antihistamine And Decongestant Combinations; Cough Suppressant And Expectorant Combinations
• 5) By Antibiotics: Macrolides; Penicillins; Cephalosporins
• 6) By Acid Blockers: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists
• 7) By Other Drug Classes: Mucolytics; Cough Suppressants; Herbal Remedies
• Companies Mentioned: Tris Pharma Inc.; Pfizer Inc.; Johnson & Johnson Co; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Cough Market Characteristics

3. Chronic Cough Market Trends And Strategies

4. Chronic Cough Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Chronic Cough Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Cough PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Cough Market Growth Rate Analysis
• 5.4. Global Chronic Cough Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Cough Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Cough Total Addressable Market (TAM)

6. Chronic Cough Market Segmentation

• 6.1. Global Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Corticosteroids
• Decongestants
• Combination Drug
• Antibiotics
• Acid Blockers
• Other Drug Classes
• 6.2. Global Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Inhalational
• Injectable
• Other Route Of Administrations
• 6.3. Global Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Centers
• Other End Users
• 6.4. Global Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Chronic Cough Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines
• Second-Generation Antihistamines
• 6.6. Global Chronic Cough Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inhaled Corticosteroids
• Systemic Corticosteroids
• 6.7. Global Chronic Cough Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Decongestants
• Nasal Decongestants
• 6.8. Global Chronic Cough Market, Sub-Segmentation Of Combination Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamine And Decongestant Combinations
• Cough Suppressant And Expectorant Combinations
• 6.9. Global Chronic Cough Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Macrolides
• Penicillins
• Cephalosporins
• 6.10. Global Chronic Cough Market, Sub-Segmentation Of Acid Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Pump Inhibitors (PPIs)
• H2-Receptor Antagonists
• 6.11. Global Chronic Cough Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mucolytics
• Cough Suppressants
• Herbal Remedies

7. Chronic Cough Market Regional And Country Analysis

• 7.1. Global Chronic Cough Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Cough Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Cough Market

• 8.1. Asia-Pacific Chronic Cough Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Cough Market

• 9.1. China Chronic Cough Market Overview
• 9.2. China Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Cough Market

• 10.1. India Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Cough Market

• 11.1. Japan Chronic Cough Market Overview
• 11.2. Japan Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Cough Market

• 12.1. Australia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Cough Market

• 13.1. Indonesia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Cough Market

• 14.1. South Korea Chronic Cough Market Overview
• 14.2. South Korea Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Cough Market

• 15.1. Western Europe Chronic Cough Market Overview
• 15.2. Western Europe Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Cough Market

• 16.1. UK Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Cough Market

• 17.1. Germany Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Cough Market

• 18.1. France Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Cough Market

• 19.1. Italy Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Cough Market

• 20.1. Spain Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Cough Market

• 21.1. Eastern Europe Chronic Cough Market Overview
• 21.2. Eastern Europe Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Cough Market

• 22.1. Russia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Cough Market

• 23.1. North America Chronic Cough Market Overview
• 23.2. North America Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Cough Market

• 24.1. USA Chronic Cough Market Overview
• 24.2. USA Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Cough Market

• 25.1. Canada Chronic Cough Market Overview
• 25.2. Canada Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Cough Market

• 26.1. South America Chronic Cough Market Overview
• 26.2. South America Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Cough Market

• 27.1. Brazil Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Cough Market

• 28.1. Middle East Chronic Cough Market Overview
• 28.2. Middle East Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Cough Market

• 29.1. Africa Chronic Cough Market Overview
• 29.2. Africa Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Cough Market Competitive Landscape And Company Profiles

• 30.1. Chronic Cough Market Competitive Landscape
• 30.2. Chronic Cough Market Company Profiles
  • 30.2.1. Tris Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Cough Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Glaxo SmithKline Plc
• 31.5. Merck KGaA
• 31.6. Reckitt Benckiser Group plc
• 31.7. Glenmark Pharmaceuticals Ltd
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Mylan NV
• 31.10. Aurobindo Pharma Ltd.
• 31.11. Cipla Limited
• 31.12. Apotex Inc.
• 31.13. Hikma Pharmaceuticals Plc
• 31.14. Amneal Pharmaceuticals LLC
• 31.15. Mount Sinai Health System

32. Global Chronic Cough Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Cough Market

34. Recent Developments In The Chronic Cough Market

35. Chronic Cough Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Cough Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Cough Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Cough Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer